PROCF — Sofgen Pharma SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Sofgen Pharma SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-10.4	-101	36.1	40.3	-68.3
Depreciation
Amortisation
Non-Cash Items	65.7	171	-8.04	30.9	61
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-0.846	-47.8	-29.4	18.2	75.6
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	70.9	37.3	15.6	108	88.4
Capital Expenditures	-17.9	-24.5	-34.1	-32.8	-25
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	0.827	0.822	1.74	-1.84	-1.75
Sale of Fixed Assets
Change in Net Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-17.1	-23.7	-32.4	-34.6	-26.8
Financing Cash Flow Items	-20.9	58.4	-17.5	-35	-33.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-40.5	58	-12.8	-97.8	-50.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	2.19	67.9	-29.1	-25.5	12.8